陳均豪 |
單位:
放射腫瘤科 |
現職:
- 馬偕醫院放射腫瘤科資深主治醫師
- 馬偕醫護管理專科學校專任助理教授
|
- 中國醫藥大學醫學系 (MD)
- 陽明大學生物醫學影像暨放射科學研究所博士 (PhD)
|
- 放射腫瘤科專科醫師
- 台灣安寧緩和醫學專科
- Visiting clinician at Mayo Clinic College of Medicine and Science, Division of Radiation Oncology, Arizona USA (January 2019)
|
主治項目或專長:
|
論文研究:
- YI-CHUN CHIEN, YING-HSIANG CHOU, WEI-HSUN WANG, JOHN CHUN-HAO CHEN, WEN-SHIN CHANG, CHIA-WEN TSAI, DA-TIAN BAU and JENG-JONG HWANG. Therapeutic Efficacy Evaluation of Pegylated Liposome Encapsulated With Vinorelbine plus 111In Repeated Treatments in Human Colorectal Carcinoma With Multimodalities of Molecular Imaging. Journal name: Cancer Genomics and Proteomics (CGP). 2019 (Accepted)
- Chen JC et al. Enhanced cytotoxicity of human hepatocellular carcinoma cells following pretreatment with sorafenib combined with trichostatin A. Oncol Lett. 2019 Jan;17(1):638-645.
- Chen JC et al. Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model. Oncotarget. 2016 Dec 20;7(51):85450-85463.
- Chien YC, Chen JC, Lin WC, Ding HJ, Wang HE, Kao CH, Hwang JJ. Using [¹⁸F]FBAU for imaging brain tumor progression in an F98/tk-luc glioma-bearing rat model. Oncol Rep. 2014 Aug;32(2):691-9.
- Hsu FT, Chang B, Chen JC, Chiang IT, Liu YC, Kwang WK, Hwang JJ,5.Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo. Sci Rep. 2015 Oct 21;5:15391.
|
|